retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & hormone receptor drug Retatrutide (4 x 10mg Vial)
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13








/assets/production/practices/bb098bde1976b73281d3b963c3dfa64815de4cfc/images/2780379.jpeg)



/sc-assets/prd/practices/af82eb1e-beb5-444f-abf2-eb06cfba4755/AdobeStock_26372862.jpeg)


















